SLS
SELLAS Life Sciences Group, Inc.
Recent 8-K filings for SLS
Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.
-
May 12, 2026 20:07 UTC other_material item 2.02item 9.01
SELLAS reports 78 events in REGAL AML trial; Q1 net loss $8.4M, cash $107.1M
source · SLS on sec.gov